Key facts
| Price (PPV) | 92 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | périndoprilindapamide |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09BA04 |
| Manufacturer | SOTHEMA |
| Presentation | Boite de 30 |
| Hospital price | 57.50 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l'hypertension artérielle essentielle chez l'adulte. INOPRIL PLUS est indiqué chez less patients chez qui la pression artérielle est insuffisamment contrôlée par périndopril seul.
Find an open pharmacy
On-call pharmacies near you
About Inopril Plus 4 mg / 1.25 mg
Inopril Plus 4 mg / 1.25 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by SOTHEMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Inopril Plus 4 mg / 1.25 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Inopril Plus 4 mg / 1.25 mg
Answers to common questions from Moroccan patients about this drug.